The Uromigos are joined by Christian Kollmannsberger, MD, FRCPC, to discuss his presentation at the ASCO GU Cancers Symposium on utilizing miR371 as a biomarker for germ cell tumors to help optimize patient management by improving decision-making. Dr. Kollmannsberger is a medical oncologist at the British Columbia Cancer Agency Vancouver Cancer Centre, and Clinical Professor at the University of British Columbia. ...
The Uromigos: Testis Cancer
Hear Thomas Powles, MD, and Brian Rini, MD, FASCO, discuss research and news on testis cancer.
Advertisement
Darren Feldman describes different approaches to relapsed germ cell tumors and the TIGER study.
Silke Gillessen discusses the back-to-back JCO papers on risk classification for germ cell cancer.
Christian Kollmannsberger gets into the Christmas spirit by discussing highlights of 2020 in the world of testis cancer.
Dr. Jan Oldenburg discusses stage 1 testis cancer treatment choices, the dilemma of high-dose therapy for relapse, and more.
Advertisement
